covaxin phase 3 trials news

Bharat Biotech’s Covaxin 3rd phase clinical trials show 77.8% overall efficacy rate; vaccine 65.2% effective against Delta variant

by
Bharat Biotech’s Covaxin 3rd phase clinical trials show 77.8% overall efficacy rate; vaccine 65.2% effective against Delta variant

In a significant development, indigenously developed Bharat Biotech’s Coronavirus vaccine Covaxin has been found to be 77.8 percent effective against symptomatic Coronavirus infections, the result of the third phase of clinical trials of the vaccine showed. While the efficacy rate of the vaccine remained 77.8 percent against symptomatic Covid-19 cases, the trial results found that … Read more

Covaxin: Bharat Biotech to release 3rd phase efficacy data in 7-8 days,

by
Covaxin: Bharat Biotech to release 3rd phase efficacy data in 7-8 days,

Consequently, the Hyderabad-based pharma company had also released phase-3 interim clinical data that had shown vaccine efficacy rate of 78 percent in April this year. The third phase clinical data of Coronavirus vaccine developed by Hyderabad-based Bharat Biotech is going to be released in a week’s time, VK Paul who is the head of the … Read more